ArticleResearch (Washington, D.C.)2025
Dynamic Polarization Control of Nonlinear Terahertz Photoresponse via Topological Phase Transitions.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise modulation of topologically protected states via external stimuli, such as electric, optical, and magnetic fields, is a cornerstone for advancing robust topological photonics and quantum technologies. However, the realization of dynamic and noninvasive control remains constrained by the high-energy thresholds of conventional stimuli, which can disrupt delicate topological states. Here, we employ low-energy terahertz excitation to directly probe the photoresponse across a temperature-induced topological phase transition in ultrathin ZrTe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.